Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Rybicki

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Oncology Reports|October 4, 2006
Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathologyRobert D Odze, John E Tomaszewski, Emma E Furth, et al.
British Journal of Haematology|October 14, 2009
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposideRobert M Dean, Brad Pohlman, John W Sweetenham, et al.
The American Journal of Gastroenterology|August 2, 2008
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsiesErinn Downs-Kelly, Joel E Mendelin, Ana E Bennett, et al.
Leukemia & Lymphoma|August 13, 2009
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphomaStephen D Smith, Brian J Bolwell, Anjali S Advani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Blood Advances|September 19, 2019
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantationBetty K Hamilton, Lisa A Rybicki, David Grove, et al.
Journal of Gastrointestinal Cancer|October 14, 2016
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative OutcomesMichael J McNamara, David J Adelstein, Daniela S Allende, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimenMichael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2019
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell TransplantationBrian T Hill, Lisa A Rybicki, Theresa A Urban, et al.
Gastroenterology|February 13, 2013
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polypsJoanne Ngeow, Brandie Heald, Lisa A Rybicki, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Oncology Reports|October 4, 2006
Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathologyRobert D Odze, John E Tomaszewski, Emma E Furth, et al.
British Journal of Haematology|October 14, 2009
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposideRobert M Dean, Brad Pohlman, John W Sweetenham, et al.
The American Journal of Gastroenterology|August 2, 2008
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsiesErinn Downs-Kelly, Joel E Mendelin, Ana E Bennett, et al.
Leukemia & Lymphoma|August 13, 2009
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphomaStephen D Smith, Brian J Bolwell, Anjali S Advani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 26, 2018
Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell TransplantationSagar S Patel, Lisa A Rybicki, Donna Corrigan, et al.
Blood Advances|September 19, 2019
Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantationBetty K Hamilton, Lisa A Rybicki, David Grove, et al.
Journal of Gastrointestinal Cancer|October 14, 2016
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative OutcomesMichael J McNamara, David J Adelstein, Daniela S Allende, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimenMichael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2019
Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell TransplantationBrian T Hill, Lisa A Rybicki, Theresa A Urban, et al.
Gastroenterology|February 13, 2013
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polypsJoanne Ngeow, Brandie Heald, Lisa A Rybicki, et al.
Pageof 11